Por: New York Post Business September 30, 2023
An inflation measure closely watched by the Federal Reserve ticked higher in August as steep prices continue to . The personal consumption expenditures index showed that consumer prices rose 0.4% from the previous month, according to the Labor Department. On an annual basis, prices climbed 3.5% – up from 3.3% recorded the previous month, underscoring the challenge of . The figures were both in line with estimates from Refintiv... + full article
New York Post USA Business July 28, 2023
Signs that inflation pressures in the United States are steadily easing emerged Friday in reports that consumer prices rose in June at their slowest pace in more than two years and that wage growth cooled last quarter. Together, the figures provided the latest signs that the... + más
What we know about the new COVID-19 variant XBB | The Boston Globe
Preferred Stocks Offer a Better Way to Bet on Banks | MarketWatch
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
ABC News USA Business December 07, 2022
WASHINGTON -- Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year,... + más
Speedier drug approvals hit slowdown as FDA faces scrutiny | ABC News
Speedier drug approvals hit slowdown as FDA faces scrutiny | WPLG Local 10
ABC News USA Health December 07, 2022
WPLG Local 10 USA Health December 07, 2022
WASHINGTON – Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the year,... + más
Associated Press USA Politics December 07, 2022
WASHINGTON (AP) — Expedited drug approvals slowed this year as the Food and Drug Administration’s controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders.With less than a month remaining in the... + más
Fox Business USA Business September 30, 2022
Aegon Asset Management chief macro strategist Frank Rybinski argues until there is a 'dovish Fed pivot' market volatility will persist on 'The Claman Countdown.' The Federal Reserve's accelerated again in August, keeping prices elevated near a... + más
Fed’s Preferred Inflation Measure Comes In Hot | Forbes
Fed Governors Shed No New Light On 4.6% Peak Funds Rate | Forbes
About iurex | Privacy Policy | Disclaimer |